Studies to further delineate the mechanism of action of AR/p52-02 and/or analogues may help further the understanding of how AR and p52 are important in castration-resistant prostate cancer and potentially unearth additional pathway(s) targets for development of therapies for prostate cancer. The gene discussed is AR; the disease is prostate cancer.